Wednesday- Saturday, September 7-10, 2016
550 First Avenue
Alumni Hall, Classroom B
New York, NY 10016
*After 12 pm on September 5, 2016, only onsite registration is available, provided the course has not reached capacity. Onsite registrants will incur an additional $20 fee. Registration is non-transferable.
Glenn I. Fishman, MD
Steven M. Kobren, MD
Reduced Fee*: $495
*Reduced fee applies to NYU School of Medicine alumni, former residents and fellows; physicians-in-training; physicians employed by the Department of Veterans Affairs Medical Center; full-time active military personnel; nurse practitioners; retired physicians; and all other non-physician healthcare professionals.
- Practicing cardiologists seeking continuing medical education and knowledge update
- Practicing cardiologists preparing for Board Certification or Recertification
- Fellows preparing for the Board Certification Examination
The NYU Comprehensive Cardiology Seminar and Board Review will provide an intensive and comprehensive review of cardiovascular medicine. The program will focus on current guidelines and appropriate use criteria in general clinical cardiology, clinical cardiac electrophysiology, invasive cardiology, cardiovascular prevention and cardiovascular genetics. In addition to thematic lectures, the program will include review sessions, case-based questions and review of images in cardiology and electrocardiograms. The program will also include presentations on changes in the health-care system and their potential impact on the practice of evidence-based quality cardiovascular medicine. This course is of particular value to those preparing for the Board Certification exam. There will be supplementary content that includes practice sessions on test-taking skills and review of images in cardiology and electrocardiograms similar to the materials tested on the board examination. A full-range of educational tools, including interactive self-assessment activities, will be embedded within the didactic lectures.An audience response system will enable participants to receive immediate feedback on their understanding of presented material.
Statement of Need
Progress in interventional cardiology technology and technique has rapidly accelerated in recent years. Depending on the training and skill of the cardiologist, as well as the quality of available imaging and catheterization equipment, the quality of care for patients with structural heart diseases can vary markedly. Paradoxically, the very rapid advances in technology that make interventional cardiology an increasingly effective subspecialty creates an inherent gap in knowledge for practicing cardiologists. There is a need to close this gap in quality cardiovascular disease management so that interventions that represent state-of-the-art care are implemented. Management of heart failure requires a multimodal approach. It involves a combination of lifestyle modifications, medications, and possibly the use of devices or surgery. There is significant evidence of a practice gap in the treatment of congestive heart failure, particularly the underuse of β-blockers and aldosterone antagonists which have been shown to provide mortality benefit. The science of arrhythmia is central to cardiology. Atrial fibrillation is the most common form of arrhythmia. About 2.5 million Americans have atrial fibrillation. As the population ages, it is becoming more common: 2 to 3 percent of 60-year-olds have atrial fibrillation, but the rate rises to 12 percent for 80-year-olds. Once viewed as a nuisance, not necessarily something that required aggressive intervention, atrial fibrillation is now seen as a major risk factor for stroke, and it is clear that atrial fibrillation plays a role in stroke and is a quality-of-life problem. Medication has long been the mainstay of treatment for atrial fibrillation; however, several studies show its effectiveness is limited. Cardiologists now perform surgical ablations where the errant electrical signals originate. There are different ablation techniques being used and there is a need to recognize the comparative effectiveness and the risks possible with each approach. There is also a need for clinicians to be better able to evaluate clinical situations where ablation may be a first-line treatment for atrial fibrillation rather than an option for patients who don’t improve after drug therapy. Proper selection of noninvasive testing remains a constantly evolving field. Newer types of tests are constantly being introduced into the field, creating a gap in the clinical practice of many cardiologists. Clinicians need to be updated on these newer diagnostic tools and find the proper clinical situations for their use. Prevention of cardiovascular disease is one of the major accomplishments of the past sixty years. The use of lipid lowering and antihypertensive medications has proven to be highly effective. To prevent stroke, doctors often prescribe a range of blood thinners. There are considerable differences in the clinical effects of each class of drugs, based on their mechanism of action. Cardiologists need to be expert in the development of effective treatment regimens. This expertise derives from a comprehensive knowledge of clinical trial results as well as an understanding of the design of these studies and the variables they address.
At the conclusion of this activity, participants should be able to:
- Outline updated guidelines relative to interventional cardiology
- Describe the latest technological advances in interventional cardiology and implement appropriately to optimize patient outcomes
- Evaluate newer medications to treat CHF and prescribe appropriately to ensure patient safety
- Review the currently available options of therapy and utilize newer modalities, such as ablation, atrial closure devices and newer anticoagulation regimens for optimal patient outcomes
- Evaluate the newer noninvasive tests available to diagnose and prognosticate patients
- Describe the clinical effects of each class of anticoagulants and prescribe appropriately to prevent stroke or minimize untoward outcomes
The NYU Post-Graduate Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The NYU Post-Graduate Medical School designates this live activity for a maximum of 26.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to request a refund, you must email firstname.lastname@example.org no later than 14 days prior to the first day of the course. An administrative fee of $75 will be deducted from your refund. Cancellations or no-shows after this date are not eligible for a refund.
Course Cancellation Policy
If a course is cancelled due to inclement weather, insufficient enrollment, or any other reason, NYU PGMS will refund registration fees in full. NYU PGMS will provide at least two weeks’ advance notice if cancelling due to insufficient enrollment and as soon as possible in all other circumstances. NYU PGMS is not responsible for any airfare, hotel, or other non-cancellable costs incurred by the registrant.